NCT06707623 CPET Guided Rehab vs Physiotherapy in Patients With Dysfunctional Breathing
| NCT ID | NCT06707623 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Evangelismos Hospital |
| Condition | Dysfunctional Breathing |
| Study Type | INTERVENTIONAL |
| Enrollment | 78 participants |
| Start Date | 2024-11-27 |
| Primary Completion | 2028-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 78 participants in total. It began in 2024-11-27 with a primary completion date of 2028-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this study the efficacy of a pulmonary rehabilitation program tailored to the needs of patients with dysfunctional breathing (DB) will be investigated using cardiopulmonary exercise testing. The pulmonary rehabilitation program will be compared with physiotherapy which is currently the mainstream therapy of DB.
Eligibility Criteria
Inclusion Criteria: * Dysfunctional breathing (DB) diagnosed with CPET. * Adult patients (\>18 years of age) * Able and willing to attend an outpatient multidisciplinary, supervised rehabilitation program of a total duration of two months (8 weeks). * Able and willing to attend 5 physiotherapy sessions over a period of 9 weeks. * Sign an informed consent. Exclusion Criteria: * No underling pathology explaining dyspnea and DB in CPET (e.g normal dead space to tidal volume ratio (VD/Vt) and normal alveolar-arterial (A-a) gradient.) * Patients with COPD * Patients with uncontrolled asthma * Patients with post-exertional malaise (PEM). * Patients that cannot attend an outpatient rehabilitation program like suffering from dementia, chronically paralyzed, with paraplegia, multiple injuries, or other serious orthopaedic problems that cause disability or suffer from very serious underlying diseases such as end-stage cancer, and patients with neurological diseases that cause disability, require specialized rehabilitation clinics and special interventions (speech therapy, kinesiotherapy, etc.).
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06707623 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Dysfunctional Breathing. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06707623 currently recruiting?
Yes, NCT06707623 is actively recruiting participants. Contact the research team at silverakos@gmail.com for enrollment information.
Where is the NCT06707623 trial being conducted?
This trial is being conducted at Athens, Greece.
Who is sponsoring the NCT06707623 clinical trial?
NCT06707623 is sponsored by Evangelismos Hospital. The trial plans to enroll 78 participants.